ibrutinib noun1 •A targeted covalent inhibitor of Bruton's tyrosine kinase and hence used in treating B cell malignancies.A recent high-throughput screen identified various compounds such as PI3K or BCL2 inhibitors that can be combined favorably with ibrutinib. — 2015
